If the US-Iran ceasefire holds, the markets may see some recovery. The movement of crude oil prices and its impact on the markets supports ...

Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...

As nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...

Shares of Medplus Health Services rose 2.1% to close at ₹719 on Monday. In last one month, the company's shares have moved up 5.46% while t...

Billionaire Azim Premji's PE firm Premji Invest, through its arm PI Opportunities Fund - I, sold 68.93 lakh shares or 5.77 per cent stake i...

The promoter has raised ₹350 crore in debt from Modulus Alternatives to help with the buyout. The fund, borrowed at the promoter level, is ...

Stocks that were in focus include names like Medplus Health Services which hit a fresh 52-week high, Sheela Foam rose more than 4% with str...

Stock has given breakout from symmetrical triangular pattern with a bullish crossover in its MACD.

Pharmacy chain MedPlus Health Services has launched a discount scheme on up to 500 off-patent therapeutic and chronic medicines under its b...

Medplus Health Services' shares rose by 12% to Rs 772.7, due to its two-fold rise in profits in the March quarter, primarily boosted by str...

Gross margin was impressive at 21.7%, upheld by private label share and store expansion was on track with 614 stores in H1FY23. It had a ‘b...

Edelweiss said Medplus’s sheer scale and value proposition puts it way ahead in the league. "Its integrated supply chain, aggressive store ...

The majority of analysts are bullish on the counter and recommend it to hold for the long run. They are bullish on the growth prospects, de...

The Rs 1,398.30 crore IPO of Medplus Health Services was open for subscription between December 13-15. The company sold its shares in the r...

In the unofficial market, the pharmacy retailer is commanding a mild premium of Rs 90-100 per share, a premium of 10-12 per cent over its i...

At the issue price, MedPlus would trade at 3.1x FY21 P/S & 40x FY21 EV/EBITDA, said Aditya Birla Capital, which has suggested investors wit...

Pharmacy chain Medplus Health Services will open its first five regional diagnostic centres in the next two days and has plans for 50 more ...